Tyscon Pharmaceuticals
Drotaverine (80mg) + Mefenamic Acid (250mg)
Scomef DV 80mg/250mg Tablet is a combination medicine used to treat abdominal pain, bloating, discomfort, and cramps by relaxing stomach and gut muscles.
Tablet
Scomef DV 80mg/250mg Tablet is taken with food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your healthcare team know about all other medications you are taking as some may affect or be affected by this medicine.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Scomef DV 80mg/250mg Tablet is to be taken with food.
Diarrhea Nausea Vomiting Stomach pain Dryness in mouth Loss of appetite Feeling thirsty Heartburn
It is unsafe to consume alcohol with Scomef DV 80mg/250mg Tablet.
Information regarding the use of Scomef DV 80mg/250mg Tablet during breastfeeding is not available. Please consult your doctor.
Scomef DV 80mg/250mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Scomef DV 80mg/250mg Tablet is a combination of two medicines: Drotaverine and Mefenamic Acid, which relieves abdominal pain and cramps. Drotaverine is an anti-spasmodic medicine which relieves contractions (spasms) associated with smooth muscles in the abdomen. Mefenamic Acid is a non-steroidal anti-inflammatory drug (NSAID) which works by blocking the release of certain chemical messengers that cause abdominal pain and inflammation (swelling).
Take it with food to prevent an upset stomach. Don't drive or do anything that requires mental focus until you know how it affects you. Avoid consuming alcohol while taking Scomef DV 80mg/250mg Tablet. If you get diarrhea while taking this medicine, stop taking it and consult your doctor. Your doctor may regularly monitor your kidney and liver function if you are taking this medicine for long-term treatment.
Scomef DV 80mg/250mg Tablet is a combination medication that contains Drotaverine and Mefenamic acid. It helps to relieve abdominal pain by relaxing muscles in the abdomen and reducing inflammation.
Yes, Scomef DV 80mg/250mg Tablet is generally considered safe for most patients experiencing abdominal pain. However, some common side effects may include nausea, vomiting, heartburn, diarrhea, loss of appetite, dry mouth, weakness, and sleepiness. If you experience any persistent problems or severe side effects, consult your doctor promptly.
Scomef DV 80mg/250mg Tablet is typically used for short-term relief of abdominal pain. You can discontinue use once your symptoms improve, but follow the advice provided by your physician if they recommend continued treatment.
Yes, taking Scomef DV 80mg/250mg Tablet may lead to nausea and vomiting. To minimize these side effects, try consuming the medication with milk or food and avoid fatty or fried foods. If you experience persistent vomiting, consult your doctor for guidance on managing dehydration.
Yes, using Scomef DV 80mg/250mg Tablet may result in dry mouth. To alleviate this symptom, drink plenty of water regularly throughout the day and keep some by your bed at night. You can also use lip balm to soothe dry lips.
No, taking more than the recommended dose of Scomef DV 80mg/250mg Tablet may increase your risk of side effects. If you experience severe or persistent pain despite following the dosage instructions, consult your doctor for re-evaluation and guidance.
To maintain the quality and potency of Scomef DV 80mg/250mg Tablet, store it in its original container or pack tightly closed. Dispose of any unused medication responsibly and ensure it is inaccessible to children, pets, and other individuals.